Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01553942
7:10:chronic_disease
known HIV carrier
1
[ "known", "HIV", "carrier" ]
[ 0, 2, 0 ]
NCT01522768
25:46:treatment,37:46:treatment,71:84:treatment,86:103:treatment,127:144:treatment,150:173:treatment,289:305:treatment,,363:371:treatment,,548:563:treatment
Additional experimental anti-cancer treatment and/or standard chemo-, immunotherapy, hormone treatment (with the exception of megestrol acetate), or concurrent radiotherapy is not allowed concomitantly with the administration of study treatment (with the exception listed in section 9.0) 89Zr-trastuzumab use as imaging agent for 89Zr-trastuzumab PET permitted. Afatinib is a substrate of P-gp and its plasma concentrations can be affected by the use of P-gp inhibitors (data on file) and it is also likely that P-gp inducers could also influence afatinib plasma concentrations
1
[ "Additional", "experimental", "anti-cancer", "treatment", "and/or", "standard", "chemo-", ",", "immunotherapy", ",", "hormone", "treatment", "(", "with", "the", "exception", "of", "megestrol", "acetate", ")", ",", "or", "concurrent", "radiotherapy", "is", "not", "allowed", "concomitantly", "with", "the", "administration", "of", "study", "treatment", "(", "with", "the", "exception", "listed", "in", "section", "9.0", ")", "89Zr-trastuzumab", "use", "as", "imaging", "agent", "for", "89Zr-trastuzumab", "PET", "permitted", ".", "Afatinib", "is", "a", "substrate", "of", "P-gp", "and", "its", "plasma", "concentrations", "can", "be", "affected", "by", "the", "use", "of", "P-gp", "inhibitors", "(", "data", "on", "file", ")", "and", "it", "is", "also", "likely", "that", "P-gp", "inducers", "could", "also", "influence", "afatinib", "plasma", "concentrations" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02393794
19:36:chronic_disease,47:94:chronic_disease,96:115:chronic_disease,120:131:chronic_disease
Other significant ECG abnormalities including 2nd degree atrio-ventricular (AV) block type II, 3rd degree AV block, or bradycardia
1
[ "Other", "significant", "ECG", "abnormalities", "including", "2nd", "degree", "atrio-ventricular", "(", "AV", ")", "block", "type", "II", ",", "3rd", "degree", "AV", "block", ",", "or", "bradycardia" ]
[ 0, 0, 2, 2, 0, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 2 ]
NCT01072370
1:9:chronic_disease
diarrhea
1
[ "diarrhea" ]
[ 2 ]
NCT02340156
1:6:cancer
Tumor foci detected below the tentorium or beyond the cranial vault
1
[ "Tumor", "foci", "detected", "below", "the", "tentorium", "or", "beyond", "the", "cranial", "vault" ]
[ 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02395393
35:58:treatment
to be unable to safely tolerate a bronchoscopic procedure
1
[ "to", "be", "unable", "to", "safely", "tolerate", "a", "bronchoscopic", "procedure" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01947673
22:46:chronic_disease
clinical evidence of congestive heart failure
1
[ "clinical", "evidence", "of", "congestive", "heart", "failure" ]
[ 0, 0, 0, 2, 2, 2 ]
NCT02565199
9:19:chronic_disease,,
Current depression (score more than 7 on the Hamilton Depression Rating Scale (HDRS))
1
[ "Current", "depression", "(", "score", "more", "than", "7", "on", "the", "Hamilton", "Depression", "Rating", "Scale", "(", "HDRS", ")", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02266329
,398:413:treatment
Participation in a headache support group or other activity such as meditation or yoga intended to mitigate headache or other chronic pain must be stable for at least 4 weeks prior to beginning the preliminary screening period and should be intended to be continued for the duration of the trial. Participants will be encouraged to defer enrolling in such activities until they have completed the treatment trial
1
[ "Participation", "in", "a", "headache", "support", "group", "or", "other", "activity", "such", "as", "meditation", "or", "yoga", "intended", "to", "mitigate", "headache", "or", "other", "chronic", "pain", "must", "be", "stable", "for", "at", "least", "4", "weeks", "prior", "to", "beginning", "the", "preliminary", "screening", "period", "and", "should", "be", "intended", "to", "be", "continued", "for", "the", "duration", "of", "the", "trial", ".", "Participants", "will", "be", "encouraged", "to", "defer", "enrolling", "in", "such", "activities", "until", "they", "have", "completed", "the", "treatment", "trial" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02365467
16:26:chronic_disease,28:36:chronic_disease,41:56:chronic_disease
Subject has an aneurysmal, tortuous, or atherosclerotic LSA
1
[ "Subject", "has", "an", "aneurysmal", ",", "tortuous", ",", "or", "atherosclerotic", "LSA" ]
[ 0, 0, 0, 2, 0, 2, 0, 0, 2, 0 ]
NCT02452697
68:89:treatment
Patients likely to have a significantly better durable response to allogeneic transplant alone (better than 60% progression free longer than 2 years)
1
[ "Patients", "likely", "to", "have", "a", "significantly", "better", "durable", "response", "to", "allogeneic", "transplant", "alone", "(", "better", "than", "60", "%", "progression", "free", "longer", "than", "2", "years", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02581215
83:95:cancer
Measurable disease determined using guidelines of Response Evaluation Criteria In Solid Tumors (RECIST 1.1)
1
[ "Measurable", "disease", "determined", "using", "guidelines", "of", "Response", "Evaluation", "Criteria", "In", "Solid", "Tumors", "(", "RECIST", "1.1", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT03030118
51:68:treatment,70:86:treatment,91:112:treatment
The subject is currently or has been treated with immunosuppressive, immune modifying, or cytotoxic medications as listed in Section 7.2
1
[ "The", "subject", "is", "currently", "or", "has", "been", "treated", "with", "immunosuppressive", ",", "immune", "modifying", ",", "or", "cytotoxic", "medications", "as", "listed", "in", "Section", "7.2" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT01312857
,36:45:treatment
Renal function (≤ 14 days prior to treatment start)
1
[ "Renal", "function", "(", "≤", "14", "days", "prior", "to", "treatment", "start", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02159703
39:62:cancer,70:80:cancer,93:105:cancer,
Histologically confirmed diagnosis of squamous cell carcinoma of the oropharynx, stage IVa, p16-positive on immunohistochemistry
1
[ "Histologically", "confirmed", "diagnosis", "of", "squamous", "cell", "carcinoma", "of", "the", "oropharynx", ",", "stage", "IVa", ",", "p16-positive", "on", "immunohistochemistry" ]
[ 0, 0, 0, 0, 3, 3, 3, 0, 0, 3, 0, 0, 0, 0, 3, 0, 0 ]
NCT02369458
7:10:chronic_disease,25:59:treatment,127:138:treatment,229:255:treatment
Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with the study drugs. In addition, these patients are at increased risk of lethal infections when treated with marrow-suppressive therapy. Appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when indicated
1
[ "Known", "HIV-positivity", "on", "combination", "antiretroviral", "therapy", "because", "of", "the", "potential", "for", "pharmacokinetic", "interactions", "with", "the", "study", "drugs", ".", "In", "addition", ",", "these", "patients", "are", "at", "increased", "risk", "of", "lethal", "infections", "when", "treated", "with", "marrow-suppressive", "therapy", ".", "Appropriate", "studies", "will", "be", "undertaken", "in", "patients", "receiving", "combination", "antiretroviral", "therapy", "when", "indicated" ]
[ 0, 2, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181516
1:11:treatment
Cephradine
1
[ "Cephradine" ]
[ 1 ]
NCT01915095
20:36:chronic_disease,40:49:chronic_disease,51:75:chronic_disease
Premorbid, ongoing major depression or psychosis, altered cognitive status
1
[ "Premorbid", ",", "ongoing", "major", "depression", "or", "psychosis", ",", "altered", "cognitive", "status" ]
[ 0, 0, 0, 2, 2, 0, 2, 0, 2, 2, 2 ]
NCT01920061
15:19:cancer,,,41:60:treatment,68:78:cancer
Patients with TNBC and one or two prior cytotoxic therapies in the metastatic setting
1
[ "Patients", "with", "TNBC", "and", "one", "or", "two", "prior", "cytotoxic", "therapies", "in", "the", "metastatic", "setting" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 1, 1, 0, 0, 3, 0 ]
NCT01595529
24:44:chronic_disease
A child diagnosed with congenital anomalies of the genitourinary tract
1
[ "A", "child", "diagnosed", "with", "congenital", "anomalies", "of", "the", "genitourinary", "tract" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02469857
21:48:chronic_disease
Patients with overt peripheral vascular disease in the involved area
1
[ "Patients", "with", "overt", "peripheral", "vascular", "disease", "in", "the", "involved", "area" ]
[ 0, 0, 0, 2, 2, 2, 0, 0, 0, 0 ]
NCT02471911
29:48:treatment,41:48:treatment,60:69:treatment,73:90:treatment,
Patients who have had other anti-cancer therapy, including radiation or experimental drug or therapy, within 28 days of enrollment
1
[ "Patients", "who", "have", "had", "other", "anti-cancer", "therapy", ",", "including", "radiation", "or", "experimental", "drug", "or", "therapy", ",", "within", "28", "days", "of", "enrollment" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03085485
1:7:chronic_disease
Angina symptoms
1
[ "Angina", "symptoms" ]
[ 2, 0 ]
NCT03075761
1:25:chronic_disease
congestive heart failure
1
[ "congestive", "heart", "failure" ]
[ 2, 2, 2 ]
NCT02442622
12:38:treatment
History of cortical steroid injection to affected wrist and/or thumb
1
[ "History", "of", "cortical", "steroid", "injection", "to", "affected", "wrist", "and/or", "thumb" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02582775
,,93:103:treatment
Cardiac: left ventricular ejection fraction ≥ 45%, normal EKG or approved by Cardiology for transplant
1
[ "Cardiac", ":", "left", "ventricular", "ejection", "fraction", "≥", "45", "%", ",", "normal", "EKG", "or", "approved", "by", "Cardiology", "for", "transplant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02579044
23:31:chronic_disease
Genetically-confirmed progeria
1
[ "Genetically-confirmed", "progeria" ]
[ 0, 2 ]
NCT02847689
1:21:chronic_disease
Congenital anomalies
1
[ "Congenital", "anomalies" ]
[ 2, 2 ]
NCT02574910
1:40:chronic_disease,52:77:chronic_disease,133:152:treatment
Concurrent medical condition or disease other than 21-hydroxylase deficiency that may interfere with linear growth or that requires concomitant therapy that is likely to interfere with study procedures or results
1
[ "Concurrent", "medical", "condition", "or", "disease", "other", "than", "21-hydroxylase", "deficiency", "that", "may", "interfere", "with", "linear", "growth", "or", "that", "requires", "concomitant", "therapy", "that", "is", "likely", "to", "interfere", "with", "study", "procedures", "or", "results" ]
[ 2, 2, 2, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02378714
,,171:181:treatment,
women of childbearing potential must agree to use a medically acceptable method of birth control or abstain from sexual intercourse during the time they are taking study medication and for at least one month after the medication period ends
1
[ "women", "of", "childbearing", "potential", "must", "agree", "to", "use", "a", "medically", "acceptable", "method", "of", "birth", "control", "or", "abstain", "from", "sexual", "intercourse", "during", "the", "time", "they", "are", "taking", "study", "medication", "and", "for", "at", "least", "one", "month", "after", "the", "medication", "period", "ends" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02488967
12:35:cancer,48:63:cancer,80:94:treatment,99:109:cancer,114:150:cancer,
History of non-breast malignancies (except for in situ cancers treated only by local excision and basal cell and squamous cell carcinomas of the skin) within 5 years prior to randomization
1
[ "History", "of", "non-breast", "malignancies", "(", "except", "for", "in", "situ", "cancers", "treated", "only", "by", "local", "excision", "and", "basal", "cell", "and", "squamous", "cell", "carcinomas", "of", "the", "skin", ")", "within", "5", "years", "prior", "to", "randomization" ]
[ 0, 0, 3, 3, 0, 0, 0, 3, 3, 3, 0, 0, 0, 1, 1, 0, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT02513485
23:32:chronic_disease,34:42:chronic_disease,44:52:cancer,57:74:chronic_disease
Current or history of migraines, glaucoma, melanoma, or bleeding disorder of any kind
1
[ "Current", "or", "history", "of", "migraines", ",", "glaucoma", ",", "melanoma", ",", "or", "bleeding", "disorder", "of", "any", "kind" ]
[ 0, 0, 0, 0, 2, 0, 2, 0, 3, 0, 0, 2, 2, 0, 0, 0 ]
NCT01943851
1:22:treatment,
Chemotherapy regimens given continuously or on a weekly basis with limited potential for delayed toxicity within the last 2 weeks
1
[ "Chemotherapy", "regimens", "given", "continuously", "or", "on", "a", "weekly", "basis", "with", "limited", "potential", "for", "delayed", "toxicity", "within", "the", "last", "2", "weeks" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02548351
40:61:chronic_disease,70:93:chronic_disease,95:106:chronic_disease,108:119:chronic_disease,121:124:chronic_disease,126:129:chronic_disease,131:151:chronic_disease,153:167:chronic_disease,169:182:chronic_disease,184:214:chronic_disease,216:241:chronic_disease,262:292:cancer
Evidence of other known forms of known chronic liver disease such as alcoholic liver disease, hepatitis B, hepatitis C, PBC, PSC, autoimmune hepatitis, Wilson disease, iron overload, alpha-1-antitrypsin deficiency, drug-induced liver injury, known or suspected hepatocellular carcinoma (HCC)
1
[ "Evidence", "of", "other", "known", "forms", "of", "known", "chronic", "liver", "disease", "such", "as", "alcoholic", "liver", "disease", ",", "hepatitis", "B", ",", "hepatitis", "C", ",", "PBC", ",", "PSC", ",", "autoimmune", "hepatitis", ",", "Wilson", "disease", ",", "iron", "overload", ",", "alpha-1-antitrypsin", "deficiency", ",", "drug-induced", "liver", "injury", ",", "known", "or", "suspected", "hepatocellular", "carcinoma", "(", "HCC", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 0, 0, 0, 0, 2, 0, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 3, 3, 3, 0, 0 ]
NCT02094118
8:27:treatment
Use of home oxygen therapy
1
[ "Use", "of", "home", "oxygen", "therapy" ]
[ 0, 0, 1, 1, 1 ]
NCT03078491
1:30:chronic_disease,,
End stage renal insufficiency (eGFR<30)
1
[ "End", "stage", "renal", "insufficiency", "(", "eGFR", "<", "30", ")" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT02101944
98:105:cancer
Evidence of any end organ damage criteria listed below (at any time) attributed to the patient's myeloma
1
[ "Evidence", "of", "any", "end", "organ", "damage", "criteria", "listed", "below", "(", "at", "any", "time", ")", "attributed", "to", "the", "patient", "'s", "myeloma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT01185132
1:31:cancer,
Microscopic multifocal disease is only allowed when the entire span of identified disease measures 3.0 cm or less
1
[ "Microscopic", "multifocal", "disease", "is", "only", "allowed", "when", "the", "entire", "span", "of", "identified", "disease", "measures", "3.0", "cm", "or", "less" ]
[ 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01648751
31:39:chronic_disease,46:53:treatment,55:59:treatment
Other prior interventions for prolapse (e.g. pessary, PFPT)
1
[ "Other", "prior", "interventions", "for", "prolapse", "(", "e.g", ".", "pessary", ",", "PFPT", ")" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 1, 0, 1, 0 ]
NCT01532687
,,17:41:chronic_disease,
Class III or IV congestive heart failure, as defined by the New York Heart Association (NYHA)
1
[ "Class", "III", "or", "IV", "congestive", "heart", "failure", ",", "as", "defined", "by", "the", "New", "York", "Heart", "Association", "(", "NYHA", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03080844
5:39:chronic_disease
Any neurologic or psychiatric disorder
1
[ "Any", "neurologic", "or", "psychiatric", "disorder" ]
[ 0, 2, 2, 2, 2 ]
NCT03088709
,78:90:treatment
Less than twenty-one days have elapsed since the subject's last radiation or chemotherapy prior to conditioning
1
[ "Less", "than", "twenty-one", "days", "have", "elapsed", "since", "the", "subject", "'s", "last", "radiation", "or", "chemotherapy", "prior", "to", "conditioning" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02496208
,,,,,191:200:treatment
The subject has prothrombin time (PT)/international normalized ratio (INR) or partial thromboplastin time (PTT) test >= 1.5 x the laboratory ULN within 7 days before the first dose of study treatment
1
[ "The", "subject", "has", "prothrombin", "time", "(", "PT", ")", "/international", "normalized", "ratio", "(", "INR", ")", "or", "partial", "thromboplastin", "time", "(", "PTT", ")", "test", ">", "=", "1.5", "x", "the", "laboratory", "ULN", "within", "7", "days", "before", "the", "first", "dose", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02334579
18:48:treatment
High risk group: three hormone therapy regimens
1
[ "High", "risk", "group", ":", "three", "hormone", "therapy", "regimens" ]
[ 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02472223
1:12:treatment,
Eye surgery in the last 3 months
1
[ "Eye", "surgery", "in", "the", "last", "3", "months" ]
[ 1, 1, 0, 0, 0, 0, 0 ]
NCT01873131
56:65:treatment
Willingness of parent/guardian to receive EXPERIMENTAL treatment
1
[ "Willingness", "of", "parent/guardian", "to", "receive", "EXPERIMENTAL", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT03021486
1:9:chronic_disease
Delirium as per DSM-V criteria (The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5))
1
[ "Delirium", "as", "per", "DSM-V", "criteria", "(", "The", "Diagnostic", "and", "Statistical", "Manual", "of", "Mental", "Disorders", ",", "Fifth", "Edition", "(", "DSM-5", ")", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03063892
1:23:treatment
Active hormone therapy
1
[ "Active", "hormone", "therapy" ]
[ 1, 1, 1 ]
NCT02176161
1:13:treatment
Chemotherapy
1
[ "Chemotherapy" ]
[ 1 ]
NCT02261519
12:18:cancer,,68:88:cancer,93:116:cancer
History of cancer not in remission for the last 3 years except for basal cell carcinoma and squamous cell carcinoma
1
[ "History", "of", "cancer", "not", "in", "remission", "for", "the", "last", "3", "years", "except", "for", "basal", "cell", "carcinoma", "and", "squamous", "cell", "carcinoma" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 3, 3, 3 ]
NCT02076906
1:26:treatment
Stem Cell Transplantation
1
[ "Stem", "Cell", "Transplantation" ]
[ 1, 1, 1 ]
NCT01697371
1:13:treatment,30:43:treatment,,88:97:treatment,,,,
Chemotherapy and/or targeted agent therapy must be completed at least 2 weeks prior to radiation and started at least 14 days after completion of SBPT Women of childbearing potential and male participants must practice adequate contraception
1
[ "Chemotherapy", "and/or", "targeted", "agent", "therapy", "must", "be", "completed", "at", "least", "2", "weeks", "prior", "to", "radiation", "and", "started", "at", "least", "14", "days", "after", "completion", "of", "SBPT", "Women", "of", "childbearing", "potential", "and", "male", "participants", "must", "practice", "adequate", "contraception" ]
[ 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02474199
1:11:treatment,16:29:chronic_disease,43:61:chronic_disease
Transplant for liver disease secondary to autoimmune disease
1
[ "Transplant", "for", "liver", "disease", "secondary", "to", "autoimmune", "disease" ]
[ 1, 0, 2, 2, 0, 0, 2, 2 ]
NCT02544503
8:24:treatment
Use of CNS active drugs
1
[ "Use", "of", "CNS", "active", "drugs" ]
[ 0, 0, 1, 1, 1 ]
NCT02074436
,,17:41:cancer
Age > 18 with a hematological malignancy
1
[ "Age", ">", "18", "with", "a", "hematological", "malignancy" ]
[ 0, 0, 0, 0, 0, 3, 3 ]
NCT01581580
18:20:chronic_disease
The diagnosis of ET will be confirmed on clinical examination in the NIH Movement Disorders Clinic (the diagnosis of ET will be based on bilateral
1
[ "The", "diagnosis", "of", "ET", "will", "be", "confirmed", "on", "clinical", "examination", "in", "the", "NIH", "Movement", "Disorders", "Clinic", "(", "the", "diagnosis", "of", "ET", "will", "be", "based", "on", "bilateral" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02430077
45:62:treatment,
Use of drugs which can potentially decrease hepatic steatosis during previous 3 months
1
[ "Use", "of", "drugs", "which", "can", "potentially", "decrease", "hepatic", "steatosis", "during", "previous", "3", "months" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02481765
1:11:treatment
Normal EEG
1
[ "Normal", "EEG" ]
[ 1, 1 ]
NCT02245841
78:86:chronic_disease
Although not mandatory, patients with evidence of current or previous active myositis
1
[ "Although", "not", "mandatory", ",", "patients", "with", "evidence", "of", "current", "or", "previous", "active", "myositis" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02543983
21:30:chronic_disease,58:71:chronic_disease,85:103:chronic_disease
Presence of current psychotic features or a diagnosis of Schizophrenia or any other psychotic disorder as defined in the DSM-IV
1
[ "Presence", "of", "current", "psychotic", "features", "or", "a", "diagnosis", "of", "Schizophrenia", "or", "any", "other", "psychotic", "disorder", "as", "defined", "in", "the", "DSM-IV" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02932410
,41:64:treatment
Subjects receiving a combination of > 2 PAH-specific treatments at randomization
1
[ "Subjects", "receiving", "a", "combination", "of", ">", "2", "PAH-specific", "treatments", "at", "randomization" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT01989546
23:63:treatment
Patients who have had prior treatment with any PARP inhibitors are ineligible
1
[ "Patients", "who", "have", "had", "prior", "treatment", "with", "any", "PARP", "inhibitors", "are", "ineligible" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02771626
1:17:chronic_disease,39:50:treatment,52:62:treatment,67:78:treatment,,117:127:treatment
Active infection requiring parenteral antibiotics, antivirals, or antifungals within 2 weeks prior to first dose of study drug
1
[ "Active", "infection", "requiring", "parenteral", "antibiotics", ",", "antivirals", ",", "or", "antifungals", "within", "2", "weeks", "prior", "to", "first", "dose", "of", "study", "drug" ]
[ 2, 2, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01059786
1:12:chronic_disease,,
Neutropenia (ANC less than 1000 cells/microl)
1
[ "Neutropenia", "(", "ANC", "less", "than", "1000", "cells/microl", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01494662
44:55:chronic_disease,,,
In cohort 1, patients must have measurable CNS disease, defined as at least one parenchymal brain lesion that can be accurately measured in at least one dimension with longest dimension ≥10 mm by local radiology review
1
[ "In", "cohort", "1", ",", "patients", "must", "have", "measurable", "CNS", "disease", ",", "defined", "as", "at", "least", "one", "parenchymal", "brain", "lesion", "that", "can", "be", "accurately", "measured", "in", "at", "least", "one", "dimension", "with", "longest", "dimension", "≥10", "mm", "by", "local", "radiology", "review" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01525901
1:26:chronic_disease
intracranial hypertension
1
[ "intracranial", "hypertension" ]
[ 2, 2 ]
NCT01849146
,34:47:treatment,49:67:treatment,75:82:treatment,84:102:treatment,104:115:treatment
2 weeks from administration of a non-cytotoxic, FDA-approved agent (e.g., Tarceva, hydroxychloroquine, bevacizumab, etc.)
1
[ "2", "weeks", "from", "administration", "of", "a", "non-cytotoxic", ",", "FDA-approved", "agent", "(", "e.g.", ",", "Tarceva", ",", "hydroxychloroquine", ",", "bevacizumab", ",", "etc", ".", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0 ]
NCT01912651
,39:46:treatment,48:67:treatment,93:104:treatment,109:119:treatment,147:167:cancer,208:232:treatment
current or recent (within one week of surgery) systemic antibiotic use, intolerance to both clindamycin and cephalexin, discovery of a persistent cutaneous malignancy at the site of the defect following the reconstructive procedure and previous reconstruction at the site of the skin/soft-tissue defect
1
[ "current", "or", "recent", "(", "within", "one", "week", "of", "surgery", ")", "systemic", "antibiotic", "use", ",", "intolerance", "to", "both", "clindamycin", "and", "cephalexin", ",", "discovery", "of", "a", "persistent", "cutaneous", "malignancy", "at", "the", "site", "of", "the", "defect", "following", "the", "reconstructive", "procedure", "and", "previous", "reconstruction", "at", "the", "site", "of", "the", "skin/soft-tissue", "defect" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02421315
30:48:chronic_disease
DSM-IV lifetime diagnosis of psychotic disorder
1
[ "DSM-IV", "lifetime", "diagnosis", "of", "psychotic", "disorder" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02320292
39:55:chronic_disease
Serious non-malignant disease such as active infection or other condition which in the opinion of the investigator would compromise other protocol objectives
1
[ "Serious", "non-malignant", "disease", "such", "as", "active", "infection", "or", "other", "condition", "which", "in", "the", "opinion", "of", "the", "investigator", "would", "compromise", "other", "protocol", "objectives" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01269853
,,124:133:treatment
Patients must agree to use a medically effective method of contraception during and for a period of three months after the treatment period
1
[ "Patients", "must", "agree", "to", "use", "a", "medically", "effective", "method", "of", "contraception", "during", "and", "for", "a", "period", "of", "three", "months", "after", "the", "treatment", "period" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT03016351
1:12:chronic_disease,
Head injury within last 6 months
1
[ "Head", "injury", "within", "last", "6", "months" ]
[ 2, 2, 0, 0, 0, 0 ]
NCT02908906
9:29:treatment
limited palliative radiation
1
[ "limited", "palliative", "radiation" ]
[ 0, 1, 1 ]
NCT01668563
17:25:chronic_disease,64:72:treatment,76:98:treatment
The patient and aneurysm are considered appropriate for either surgical or endovascular treatment by the treating team
1
[ "The", "patient", "and", "aneurysm", "are", "considered", "appropriate", "for", "either", "surgical", "or", "endovascular", "treatment", "by", "the", "treating", "team" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0 ]
NCT01660607
,,22:54:chronic_disease
Complex karyotype(≥3 clonal chromosomal abnormalities)
1
[ "Complex", "karyotype", "(", "≥3", "clonal", "chromosomal", "abnormalities", ")" ]
[ 0, 0, 0, 0, 2, 2, 2, 0 ]
NCT02464878
19:45:treatment,
Administration of live attenuated vaccine(s) within 2 months of enrollment
1
[ "Administration", "of", "live", "attenuated", "vaccine", "(", "s", ")", "within", "2", "months", "of", "enrollment" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02408120
21:36:chronic_disease
Clinically relevant hepatic disease
1
[ "Clinically", "relevant", "hepatic", "disease" ]
[ 0, 0, 2, 2 ]
NCT02564744
42:47:cancer
The following participants with relapsed DLBCL will be enrolled
1
[ "The", "following", "participants", "with", "relapsed", "DLBCL", "will", "be", "enrolled" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0 ]
NCT02907944
27:30:chronic_disease,
Employed at participating HIV clinic for at least 6 months
1
[ "Employed", "at", "participating", "HIV", "clinic", "for", "at", "least", "6", "months" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT00695214
12:20:allergy_name,22:33:allergy_name,35:47:allergy_name,51:59:allergy_name
Allergy to propofol, soybean oil, egg lecithin or glycerol
1
[ "Allergy", "to", "propofol", ",", "soybean", "oil", ",", "egg", "lecithin", "or", "glycerol" ]
[ 0, 0, 4, 0, 4, 4, 0, 4, 4, 0, 4 ]
NCT01815359
70:80:treatment
Any condition that would preclude the ability to deliver appropriate IP therapy
1
[ "Any", "condition", "that", "would", "preclude", "the", "ability", "to", "deliver", "appropriate", "IP", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02982226
12:29:treatment
History of radiation therapy of the affected foot
1
[ "History", "of", "radiation", "therapy", "of", "the", "affected", "foot" ]
[ 0, 0, 1, 1, 0, 0, 0, 0 ]
NCT02584309
,147:154:treatment,
measurable disease defined as lesions that can be accurately measured in at least one dimension (longest diameter to be recorded) as ≥ 10 mm with CT scan, as ≥ 20 mm by chest x-ray, or ≥ 10 mm with calipers by clinical exam
1
[ "measurable", "disease", "defined", "as", "lesions", "that", "can", "be", "accurately", "measured", "in", "at", "least", "one", "dimension", "(", "longest", "diameter", "to", "be", "recorded", ")", "as", "≥", "10", "mm", "with", "CT", "scan", ",", "as", "≥", "20", "mm", "by", "chest", "x-ray", ",", "or", "≥", "10", "mm", "with", "calipers", "by", "clinical", "exam" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01422746
23:31:chronic_disease,,,,
Previous diagnosis of diabetes, fasting glucose ≥126 mg/dL, or a hemoglobin A1c ≥6.5%
1
[ "Previous", "diagnosis", "of", "diabetes", ",", "fasting", "glucose", "≥126", "mg/dL", ",", "or", "a", "hemoglobin", "A1c", "≥6.5", "%" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00678145
15:39:chronic_disease
Patients with type 1 diabetes mellitus
1
[ "Patients", "with", "type", "1", "diabetes", "mellitus" ]
[ 0, 0, 2, 2, 2, 2 ]
NCT01799135
26:52:cancer
Histologically confirmed non-small cell lung cancer
1
[ "Histologically", "confirmed", "non-small", "cell", "lung", "cancer" ]
[ 0, 0, 3, 3, 3, 3 ]
NCT02578641
1:35:chronic_disease
Human Immunodeficiency Virus (HIV) negative
1
[ "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "negative" ]
[ 2, 2, 2, 2, 0, 0, 0 ]
NCT01422746
1:18:chronic_disease
Hyperandrogenemic
1
[ "Hyperandrogenemic" ]
[ 2 ]
NCT02566395
1:4:chronic_disease
HIV positive
1
[ "HIV", "positive" ]
[ 2, 0 ]
NCT02522468
7:20:cancer
Prior breast cancer on ipsilateral side
1
[ "Prior", "breast", "cancer", "on", "ipsilateral", "side" ]
[ 0, 3, 3, 0, 0, 0 ]
NCT02323945
42:51:chronic_disease,53:75:chronic_disease,101:122:chronic_disease,133:141:chronic_disease,158:181:chronic_disease
Concurrent severe medical illness (i.e., infection, cardiovascular disease, ossification, recurrent autonomic dysreflexia, unhealed decubiti, and history of pulmonary complications)
1
[ "Concurrent", "severe", "medical", "illness", "(", "i.e.", ",", "infection", ",", "cardiovascular", "disease", ",", "ossification", ",", "recurrent", "autonomic", "dysreflexia", ",", "unhealed", "decubiti", ",", "and", "history", "of", "pulmonary", "complications", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 2, 0, 0, 0, 0, 2, 2, 0 ]
NCT02503358
,94:103:treatment,
Estimated life expectancy, in the judgment of the investigator, which will permit receipt of treatment of 12 weeks or more
1
[ "Estimated", "life", "expectancy", ",", "in", "the", "judgment", "of", "the", "investigator", ",", "which", "will", "permit", "receipt", "of", "treatment", "of", "12", "weeks", "or", "more" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02278315
1:16:treatment,40:60:treatment,65:80:treatment
Prior treatment with or intolerance to proteasome inhibitor and immunomodulator
1
[ "Prior", "treatment", "with", "or", "intolerance", "to", "proteasome", "inhibitor", "and", "immunomodulator" ]
[ 1, 1, 0, 0, 0, 0, 1, 1, 0, 1 ]
NCT02502708
34:46:treatment,48:64:treatment,73:82:treatment
Patients previously treated with temozolomide, cyclophosphamide, and/or etoposide are eligible for enrollment
1
[ "Patients", "previously", "treated", "with", "temozolomide", ",", "cyclophosphamide", ",", "and/or", "etoposide", "are", "eligible", "for", "enrollment" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0 ]
NCT01877382
80:88:treatment
Confirmation of TP53 nonmutant status is encouraged, but not required prior to DS-3032b dosing
1
[ "Confirmation", "of", "TP53", "nonmutant", "status", "is", "encouraged", ",", "but", "not", "required", "prior", "to", "DS-3032b", "dosing" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02477839
36:59:chronic_disease,61:89:chronic_disease,91:119:chronic_disease,121:136:chronic_disease,141:149:chronic_disease
Subject has a current diagnosis of Lennox-Gastaut syndrome, epilepsia partialis continua, primary generalized epilepsy, Dravet Syndorme, or seizures that are not of partial-onset origin
1
[ "Subject", "has", "a", "current", "diagnosis", "of", "Lennox-Gastaut", "syndrome", ",", "epilepsia", "partialis", "continua", ",", "primary", "generalized", "epilepsy", ",", "Dravet", "Syndorme", ",", "or", "seizures", "that", "are", "not", "of", "partial-onset", "origin" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT03033498
24:52:chronic_disease,60:69:chronic_disease,71:88:chronic_disease
History of significant skin conditions or disorders (e.g., psoriasis, atopic dermatitis, etc.)
1
[ "History", "of", "significant", "skin", "conditions", "or", "disorders", "(", "e.g.", ",", "psoriasis", ",", "atopic", "dermatitis", ",", "etc", ".", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0 ]
NCT02114229
73:75:cancer,76:78:cancer,82:85:cancer
For Stratum A participants, histologic confirmation of the diagnosis of AT/RT or MRT may be from the original diagnosis or at the time of recurrence/progression
1
[ "For", "Stratum", "A", "participants", ",", "histologic", "confirmation", "of", "the", "diagnosis", "of", "AT/RT", "or", "MRT", "may", "be", "from", "the", "original", "diagnosis", "or", "at", "the", "time", "of", "recurrence/progression" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01631617
1:4:chronic_disease
HIV seropositiviy
1
[ "HIV", "seropositiviy" ]
[ 2, 0 ]
NCT02615353
11:21:chronic_disease
Diagnosed depression or other condition that may impact QoL
1
[ "Diagnosed", "depression", "or", "other", "condition", "that", "may", "impact", "QoL" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0 ]